Download PDF
Homœopathic Links 2024; 37(01): 038-044
DOI: 10.1055/s-0043-1777818
Case Report

Treatment of Polycystic Ovarian Syndrome through Individualised Homoeopathic Medicine: Two Case Reports

Divya Verma 
1   Central Research Institute, Lucknow under Central Council for Research in Homoeopathy, Ministry of AYUSH, Government of India, New Delhi, India.
,
Arun Kumar
2   State Homoeopathic Dispensary, Hardoi, Government of Uttar Pradesh, Uttar Pradesh, India.
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common metabolic and reproductive disorders among women of reproductive age. Women suffering from PCOS present with menstrual dysfunction and androgen excess. Two patients aged 16 and 19 years suffering from PCOS were treated successfully with individualised homoeopathic medicine. These two cases of PCOS were treated with marked improvement within 1.5 years by individualised homoeopathic medicine with change in potency and repetition as per requirement. Modified Naranjo Criteria for Homeopathy (MONARCH) was used as a tool for attributing a causal relationship between the homoeopathic intervention and outcome. Visual analogue scale was used as a tool for assessing pain during menses (dysmenorrhoea). The improvement is evident from the regularity of the menstrual cycle, along with the resolution of cysts in ovaries as evidenced by ultrasonography reports which indicate a positive response of homoeopathy in relieving the symptoms as well as pathology associated with PCOS.

Keywords

polycystic ovarian syndrome - homoeopathy - hirsutism - polycystic ovaries - hyperandrogenism - infertility

Patients' Consent

The author declares that she has obtained all appropriate patient consent forms. In the form, the patient has given written consent for clinical information to be reported in the journal. The patient understands that her name will not be published and will due to efforts be made to conceal her identity.




Publication History

Article published online:
01 February 2024

© 2024. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly Cystic ovarian syndrome: an updated overview. Front Physiol 2016; 7: 124 2022
    CrossrefPubMedGoogle Scholar
  • 2 Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P&T 2013; 38 (06) 336-355
    PubMedGoogle Scholar
  • 3 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588) 685-697
    CrossrefPubMedGoogle Scholar
  • 4 Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4 (02) 45-51
    PubMedGoogle Scholar
  • 5 Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med 2018; 40 (03) 239-246
    CrossrefPubMedGoogle Scholar
  • 6 Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93 (07) 2421-2423
    CrossrefPubMedGoogle Scholar
  • 7 Vidya Bharathi R, Swetha S, Neerajaa J. et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J 2017; 22 (04) 313-316
    CrossrefPubMedGoogle Scholar
  • 8 Hahnemann S. Organon of Medicine. 6th ed.. New Delhi, India: B Jain Publishers; 2021
    Google Scholar
  • 9 Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 2015; 7: 745-763
    CrossrefPubMedGoogle Scholar
  • 10 Rashid R, Mir SA, Kareem O. et al. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol 2022; 61 (01) 40-50
    CrossrefPubMedGoogle Scholar
  • 11 Moghetti P, Castello R, Negri C. et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85 (01) 139-146
    PubMedGoogle Scholar
  • 12 Zeng LH, Rana S, Hussain L. et al. Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Front Pharmacol 2022; 13: 874914
    CrossrefPubMedGoogle Scholar
  • 13 Parveen S, Das S. Homeopathic treatment in patients with polycystic ovarian syndrome: a case series. Homeopathy 2021; 110 (03) 186-193
    PubMedGoogle Scholar
  • 14 Oberai P, Lamba C, Manchanda R, Rath P. et at. Evaluation of homoeopathic treatment in polycystic ovary syndrome: A single-blind, randomised, placebo-controlled pilot study. Ind J Res Homeopat 2018; 12 (01) 35
    CrossrefPubMedGoogle Scholar
  • 15 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197
    Article in Thieme ConnectPubMedGoogle Scholar